MJFF today announced that it is piloting a Partnering Program designed to proactively showcase promising research results in the Foundation’s portfolio for funders who may wish to invest in their continued development. By promoting collaboration between MJFF awardees and industry groups, the Foundation aims to drive forward promising projects in PD research along the drug development pipeline.
The Partnering Program formalizes the process of developing direct, proactive relationships with industry, including advising companies about potential collaborative opportunities. It encourages select awardees to submit public overviews highlighting their organization, team, and projects. These overviews will then be made available for review by industry groups. Awardees spanning the PD drug development pipeline, from basic to clinical research, and from academia and industry alike, will be showcased on a quarterly basis.
Read the press release